Obstructive Sleep Apnea (OSA) is a prevalent condition where upper airway collapse leads to repetitive breathing pauses, hypoxemia, and fragmented sleep architecture. Approximately 1 in 5 adults has or will develop mild OSA (AHI 5–15), while 1 in 15 experiences moderate OSA (AHI 15–30). Left unmanaged, these apnoeic events trigger sympathetic surge, oxidative stress, and systemic inflammation—directly contributing to cardiovascular distress, metabolic imbalances, and neurocognitive decline (Sutherland & Cistulli, 2019).
While identifying OSA in primary care is crucial, finding a treatment modality your patient will stick with long-term is where the real clinical challenge lies.
CPAP Therapy: The Pneumatic Gold Standard
Continuous Positive Airway Pressure (CPAP) remains the gold standard treatment for OSA. By delivering continuous positive air pressure throughout the respiratory cycle, CPAP functions as a pneumatic splint to prevent upper airway collapse, regardless of where in an individual’s anatomy the obstruction occurs—much like a hardy gust of wind opening a shut or slightly ajar door.
• Efficacy & Physiology: CPAP consistently provides the greatest overall reduction in Apnea-Hypopnea Index (AHI) across all severity levels, rapidly restoring nocturnal oxygen saturation and healthy sleep architecture (Sutherland & Cistulli, 2019).
• Accessibility via “Trial before buy”: Through structured sleep clinic pathways, CPAP is highly accessible. Patients typically undergo a baseline diagnostic Polysomnography (PSG) followed by a clinical titration trial to determine their precise therapeutic pressure.
• The Adherence Challenge: Patients trial a personalized device for 4–12 weeks to gauge both symptomatic relief and functional tolerance. Because mask discomfort, nasal dryness, and aerophagia can pose significant barriers, our team of sleep educators provides continuous remote data monitoring, mask fitting, and pressure-comfort adjustments to optimize compliance.
Mandibular Advancement Splints (MAS)
When CPAP intolerance or poor compliance threatens patient outcomes, Oral Appliance Therapy specifically custom, titratable Mandibular Advancement Splints (MAS) offer a validated alternative.
Unlike pneumatic splinting, MAS works mechanically. By gently advancing and stabilizing the mandible during sleep, the device exerts forward traction on the anterior belly of the digastric, geniohyoid, and genioglossus muscles. This anterior movement displaces the hyoid bone, directly enlarging the retroglossal and velopharyngeal airway space while reducing lateral pharyngeal wall compliance (Sutherland & Cistulli, 2019).
Who is MAS Best Suited For?
• Mild-to-Moderate OSA: Patients seeking a discrete, non-invasive primary therapy (Sutherland & Cistulli, 2019).
• CPAP-Intolerant / Non-Compliant Patients: Individuals struggling with mask claustrophobia, aerophagia, or frequent travel demands.
• Anatomy- & Position-Dependent Apnea: Patients presenting with retrognathia, tongue-base collapse, or primary supine-dependent events.
